ArticleFuture medicinal chemistry2022

Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening.

Li-Chuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.